Janagliflozin Treat T2DM Monotherapy

Clinical trial NCT03811548 · UNKNOWN

Trial details

NCT number: NCT03811548
Sponsor: Sihuan Pharmaceutical Holdings Group Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Type 2

Start date: 2019-05-23
Primary completion: 2020-06-24
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.